FIELD: medicine.
SUBSTANCE: invention refers to medicine, ophthalmology, and can be used in uveal melanoma brachytherapy ensured by an ophthalmologic applicator type C with isotope Sr90+Y90 along the tumour thickness to 4 mm. Herewith the irradiation parametres are specified so that the biological cumulative effect is within 4558 to 5696 Gy2. If the tumour thickness exceeds 4 mm, brachytherapy is performed with an ophthalmologic applicator type P with isotope Ru106+Rh106. And the irradiation parametres are specified so that the biological cumulative effect is within 1451 to 2143 Gy2.
EFFECT: disclosed method allows improving biological effect of ionising radiation on uveal melanoma cells and increasing probability of complete tumour resorption.
2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF BRACHYTHERAPY OF UVEAL MELANOMA | 2016 |
|
RU2610017C1 |
| METHOD FOR PREDICTING OCCURRENCE OF EARLY AND LATE RADIATION COMPLICATIONS CAUSED BY BRACHYTHERAPY OF UVEAL MELANOMA | 2005 |
|
RU2290071C2 |
| METHOD FOR REDUCING SUPERFICIAL OPHTHALMOAPPLICATOR DOSE IN CARRYING OUT INTRAOCULAR NEOPLASMS BRACHYTHERAPY | 2005 |
|
RU2303966C2 |
| METHOD FOR TREATING INTRAOCULAR NEOPLASMS OF LARGE SIZE | 2005 |
|
RU2303965C2 |
| METHOD OF ORGAN PRESERVATION TREATMENT OF UVEAL MELANOMA | 2017 |
|
RU2655831C1 |
| ORGAN- RETAINING METHOD FOR TREATING UVEAL MELANOMA CASES | 2005 |
|
RU2288740C2 |
| METHOD OF COMBINED ORGAN-PRESERVING TREATMENT OF JUXTA- AND PARAPAPILLARY LOCALIZATION CHORIOID MELANOMA | 2019 |
|
RU2708055C1 |
| METHOD FOR EVALUATING EFFECTIVENESS OF BRACHYTHERAPY FOR INITIAL AND MODERATE CHOROIDAL MELANOMAS | 2024 |
|
RU2839875C1 |
| METHOD OF ORGAN-PRESERVING TREATMENT OF INTRAOCULAR TUMOURS | 2010 |
|
RU2452444C1 |
| METHOD OF INTERSTITIAL LASER HYPERTHERMIA OF BIG CHOROID MELANOMAS | 2007 |
|
RU2343873C1 |
